BEECHAM UNIT LAUNCHES ARTHRITIS DRUG
Beecham Group Plc <BHAM.L> said its subsidiary <Beecham Pharmaceuticals> launched a new once-a-day, prescription only medicine for the reduction of pain and inflammation caused by rheumatoid and osteoarthritis. The launch took place simultaneously in the U.K. And West Germany.     The drug, which has the approved name Nabumetone, will be introduced to doctors in the U.K. Under the brand name of Relifex and will be known as Arthaxan in West Germany.
